Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients
Authors:
- Carnevale RobertoCarnevale Roberto
- Pignatelli PasqualePPPignatelli Pasquale
- Di Santo SerenaDSDi Santo Serena
- Bartimoccia SimonaBSBartimoccia Simona
- Sanguigni ValerioSVSanguigni Valerio
- Napoleone LauraNLNapoleone Laura
- Tanzilli GaetanoTGTanzilli Gaetano
- Basili StefaniaBasili Stefania
- Violi FrancescoVFVioli Francesco
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 213 (1) , 225-234
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical implications of inflammation for cardiovascular primary preventionEuropean Heart Journal, 2010
- Role of Nadph Oxidase in AtherosclerosisFuture Cardiology, 2008
- Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin EEuropean Heart Journal, 2007
- Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic strokeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Anti-Inflammatory and Anticoagulant Effects of Pravastatin in Patients With Type 2 DiabetesDiabetes Care, 2004
- Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory PathwaysCirculation, 2003
- Cellular Antioxidant Effects of Atorvastatin In Vitro and In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Induction of NAD(P)H Oxidase by Oxidized Low-Density Lipoprotein in Human Endothelial CellsCirculation, 2001
- Inhibition of proinflammatory cytokine production by pravastatinThe Lancet, 1999
- Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.Circulation, 1994